Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
REALIVE CZS
- Development stage
- Unknown
- Lead developer
- Opsiscare Lifesciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
REALIVE CZS is a multivitamin and multimineral dietary supplement marketed by Opsiscare Lifesciences. It is formulated as a fixed-dose combination tablet containing pyridoxine hydrochloride (vitamin B6), nicotinamide (vitamin B3), cyanocobalamin (vitamin B12), folic acid (vitamin B9), chromium picolinate, zinc, and selenium. The supplement is primarily used to prevent and treat nutritional deficiencies, support nerve health, boost immunity, and maintain overall metabolic and cellular function.
- Brand names
- REALIVE CZS
- Other names
- Realive CzsRealive Czs Tabletchromium picolinate + cyanocobalamin + folic acid + nicotinamide + pyridoxine + selenium + zinc
Beyond the preview
Go deeper on REALIVE CZS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on REALIVE CZS.